DNA Plc - Repurchase of own shares on 17 July 2017

Thomson Reuters ONE |




DNA PLC        STOCK EXCHANGE RELEASE                    AT 

In the Nasdaq Helsinki

 Date                     

 Exchange transaction     Buy



 Share trading code       DNA

 Amount, shares           28 500

 Average price/share, EUR 14,1378

 Total cost, EUR          402 928


DNA now holds a total of 451 170 own shares (DNA) including the shares
repurchased on .

On behalf of DNA Plc

OP CORPORATE BANK PLC

Tomi Korpivaara                   Jari Villenheimo

Further enquiries:
Investor relations, Marja Mäkinen, tel. +358 44 044 1262, marja.makinen@dna.fi

Distribution:
Nasdaq Helsinki
Key media
www.dna.fi

DNA Plc is a Finnish telecommunications group providing high-quality voice, data
and TV services for communication, entertainment and working. DNA is Finland's
largest cable operator and the leading pay TV provider in both cable and
terrestrial networks. For DNA, the key area for growth in corporate business is
the new way of working, independent of time and place, facilitated by smart
terminal devices, diverse communications services and rapid connections. In
2016, DNA recorded net sales of EUR 859 million and an operating profit of EUR
91 million. DNA has more than 3.8 million subscriptions in its fixed and mobile
communications networks. The Group also includes DNA Store, Finland's largest
retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki
Ltd. For further information, visit www.dna.fi or follow us on Twitter @DNA_fi,
@DNA_Business and @DNA_Palvelu and Facebook.

DNA trades 170717: 
http://hugin.info/173243/R/2120878/808051.xlsx



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    
Source: DNA Oyj via GlobeNewswire

 
  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

THC Therapeutics Inc

THC Therapeutics Inc is a health and healing company in the cannabis industry. The Company is engaged in developing dHydronator which is used to reduce moisture and effectively dry out…

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…